-
Loading metrics
Budget impact analysis of durvalumab consolidation therapy vs no consolidation therapy after chemoradiotherapy in stage III non–small cell lung cancer in the context of the Chilean health care system
- Nicolás Armijo,
- Constanza Salas,
- Nazareth Espinoza,
- Manuel Espinoza,
- Carlos Balmaceda
x
- Published: July 26, 2024
- https://doi.org/10.1371/journal.pone.0307473